CoRISMA MCS Systems, Inc

Activity by year

202120222023202420252026

Partnership

Aug 6, 2021PARTNERSHIPUnited States$12.0M
GP (HK) invests $12M in CoRISMA for heart failure device rights
China Grand Pharmaceutical and Healthcare Holdings (GP (HK)) will acquire 22.2% equity in CoRISMA MCS Systems for $12 million, and obtain exclusive development, manufacturing and commercialization rights for CoRISMA's heart failure therapeutic system in Greater China and several Southeast Asian countries.
China Grand Pharmaceutical and Healthcare CoRISMA MCS Systems, Inc partner #Medical Devices grandpharm.com
Aug 5, 2021PARTNERSHIP$12.0M
Grand Pharma invests $12M in CoRISMA for heart failure device rights
Grand Pharmaceutical Group (远大医药) has entered a strategic partnership with CoRISMA MCS Systems, investing $12 million for a 22.2% stake and exclusive rights to develop and commercialize CoRISMA's heart failure treatment systems in Greater China and several Southeast Asian countries.
Grand Pharmaceutical Group investor CoRISMA MCS Systems, Inc partner #Medical Devices beta.zhitongcaijing.com

Partners

Loading…